Abstract
Purpose: This study was undertaken to estimate the incidence of retinal changes and determine the prevalence of ocular toxicity associated with tamoxifen treatment in a breast cancer population.
Methods: The study was based on a population cross-sectional survey, including 290 patients taking tamoxifen from 6 months to 12 years; 274 patients were analysed. The main outcome measures were the incidence of retinal changes and visual impairment.
Results: The incidence of retinal changes was 0.9% (3 of 274 patients). All 3 patients were asymptomatic. The length of tamoxifen treatment ranged from 39 months to 120 months in the affected patients, with cumulative tamoxifen doses ranging from 23.7 g to 73 g.
Conclusions: Retinopathy in patients receiving low doses of tamoxifen is rare and, in our study, did not result in changes in visual acuity. We found no retinopathy in patients receiving tamoxifen within the first 3 years of treatment or in patients receiving a total tamoxifen dosage of less than 23.7 g. Although retinopathy can occur in a tamoxifen-treated population its low incidence and an associated good prognosis for vision does not merit special screening for this problem.
Similar content being viewed by others
Article PDF
References
Fisher B, Constantino J, Redmond C, et al. A randomised clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 1989;320:479–84.
Kaiser-Kupfer M, Lippman M . Tamoxifen retinopathy. Cancer Treat Rep 1978;62:315–20.
Kaiser-Kupfer M, Kupfer C, Rodrigues M . Tamoxifen retinopathy: a clinicopathologic report. Ophthalmology 1981;88:89–93.
McKeown C, Swartz M, Blom J, Maggiano J . Tamoxifen retinopathy. Br J Ophthalmol 1981;65:177–9.
Vinding T, Nielsen N . Retinopathy caused by treatment with tamoxifen in low dosage. Acta Ophthalmolol (Copenh) 1983;61:45–50.
Pugesgaard T, Von Eyben F . Bilateral optic neuritis evolved during tamoxifen treatment. Cancer 1986;58:383–6.
Griffiths M . Tamoxifen retinopathy at low dosage [letter]. Am J Ophthalmol 1987;104:185–6.
Ashford A, Donev I, Tiwari R, Garrett T . Reversible ocular toxicity related to tamoxifen therapy. Cancer 1988;61:33–5.
Gerner E . Ocular toxicity of tamoxifen. Ann Ophthalmol 1989;21:420–3.
Chern S, Danis R . Retinopathy associated with low-dose tamoxifen [letter]. Am J Ophthalmol 1993;116:372–5.
Pavlidis N, Petris C, Briassoulis E, et al. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients. Cancer 1992;69:2961–4.
Beck M, Mills P . Ocular assessment of patients treated with tamoxifen. Cancer Treat Rep 1979;63:1833–4.
Longstaff S, Sigurdsson H, O'Keeffe M, et al. A controlled study of ocular effects of tamoxifen in conventional dosage in the treatment of breast carcinoma. Eur J Cancer Clin Oncol 1989;25:1805–8.
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 1992;339:71–85, 115.
Heier J, Dragoo R, Enzenauer R, Waterhouse W . Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 1994;117:772–5.
Flach A . Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity: a prospective study of 63 patients [comment]. Surv Ophthalmol 1994;38:392–3.
Author information
Authors and Affiliations
Rights and permissions
This article is cited by
-
One-year follow-up of optical coherence tomography angiography microvascular findings: macular telangiectasia type 2 versus tamoxifen retinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology (2022)
-
Ocular Toxicity of Targeted Anticancer Agents
Drugs (2021)
-
Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis
BMC Ophthalmology (2019)
-
Evaluation of adverse effects in tamoxifen exposed healthy female dogs
Acta Veterinaria Scandinavica (2010)
-
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica (2010)